|
CA5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82125999999005E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.027570E-04 |
| Normal-vs-Stage2 |
1.362540E-03 |
| Normal-vs-Stage3 |
3.376700E-03 |
| Normal-vs-Stage4 |
1.103960E-03 |
| Stage1-vs-Stage2 |
9.839400E-01 |
| Stage1-vs-Stage3 |
9.718200E-01 |
| Stage1-vs-Stage4 |
3.939800E-01 |
| Stage2-vs-Stage3 |
9.851600E-01 |
| Stage2-vs-Stage4 |
5.109800E-01 |
| Stage3-vs-Stage4 |
5.325400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7003999996934E-07 |
| Normal-vs-AfricanAmerican |
5.260300E-02 |
| Normal-vs-Asian |
1.129810E-01 |
| Caucasian-vs-AfricanAmerican |
2.495200E-01 |
| Caucasian-vs-Asian |
5.643000E-01 |
| AfricanAmerican-vs-Asian |
9.135000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.60785999999691E-05 |
| Normal-vs-Female |
7.830300E-02 |
| Male-vs-Female |
3.835600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.47679999999528E-05 |
| Normal-vs-Extreme_Weight |
4.06369999872425E-08 |
| Normal-vs-Obese |
5.002100E-04 |
| Normal-vs-Extreme_Obese |
8.644100E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.451000E-01 |
| Normal_Weight-vs-Obese |
7.823000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.327400E-01 |
| Extreme_Weight-vs-Obese |
2.420800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.383600E-01 |
| Obese-vs-Extreme_Obese |
3.324800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.258600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.765200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.25150000257679E-08 |
| Normal-vs-Age(81-100Yrs) |
2.972200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.572200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.595600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.361770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.191410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.399970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.878200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.18009999999325E-05 |
| Normal-VS-Type2 PRCC |
1.81199999449433E-08 |
| Normal-VS-KIRP CIMP |
7.682600E-01 |
| Normal-VS-Unclassified PRCC |
6.000100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.334000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.851500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.499600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.809700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.482800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.103430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.678480E-02 |
| Normal-vs-N1 |
2.155800E-02 |
| Normal-vs-N2 |
6.507800E-02 |
| N0-vs-N1 |
8.133400E-01 |
| N0-vs-N2 |
9.712000E-01 |
| N1-vs-N2 |
8.432800E-01 |
|
|
